WAT · Waters Corporation
$453.67
-0.42% last session
End-of-day data · close of 2026-10-23
Market cap
$45B
Enterprise value
$50B
Trailing P/E
114.9
Forward P/E
27.4
Dividend yield
0.0%
Beta
1.15
Avg volume
1M
Employees
16K
Daily Change %
-0.42%
5 Days Change
4.27%
10 Days Change
6.16%
30 Days Change
8.33%
60 Days Change
10.92%
Month to Day Change
7.06%
Year to Day Change
19.95%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — WAT
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-13
Latest call per bank · past 12 months
Barclays
Overweight$500
+10.2% vs priceGoldman Sachs
Buy$515
+13.5% vs priceUBS
Buy$490
+8.0% vs priceCitigroup
Buy$470
+3.6% vs priceRBC Capital
Outperform$475
+4.7% vs priceWells Fargo
Equal-Weight$400
-11.8% vs priceMorgan Stanley
Equal-Weight$390
-14.0% vs priceHSBC
Buy$435
-4.1% vs priceBank of America
Neutral$400
-11.8% vs priceJP Morgan
Neutral$345
-24.0% vs priceDeutsche Bank
Hold$330
-27.3% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-13 | TD Cowen | Maintains | Buy | $475 → $515 |
| 2026-10-07 | Barclays | Maintains | Overweight | $460 → $500 |
| 2026-10-01 | Guggenheim | Maintains | Buy | $440 → $490 |
| 2026-09-21 | Goldman Sachs | Maintains | Buy | $465 → $515 |
| 2026-09-09 | UBS | Upgrade | Neutral → Buy | $375 → $490 |
| 2026-08-27 | Piper Sandler | Upgrade | Neutral → Overweight | $400 → $480 |
| 2026-08-10 | Citigroup | Maintains | Buy | $425 → $470 |
| 2026-08-05 | TD Cowen | Upgrade | Hold → Buy | $408 → $475 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 63 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 7.0% above the 50-day MA ($424.14).
- bullish: Price vs 200-day MA: Trading 23.4% above the 200-day MA ($367.67).
- bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- bullish: MACD (12,26,9): MACD histogram is positive (+1.36) — short-term momentum is improving.
- bullish: 52-week range: Price is within 5% of the 52-week high ($457.47).
WAT Price Chart
Loading chart for WAT…
Fundamentals
About Waters Corporation
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
More in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
$249B 17.1% YTD
DHR
Danaher Corporation
$162B 1.0% YTD
NTRA
Natera, Inc.
$58B 75.2% YTD
A
Agilent Technologies, Inc.
$49B 28.7% YTD
IQV
IQVIA Holdings, Inc.
$46B 23.5% YTD
IDXX
IDEXX Laboratories, Inc.
$44B -16.2% YTD
ILMN
Illumina, Inc.
$41B 105.4% YTD
MTD
Mettler-Toledo International, I
$33B 20.8% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.